The South African breast cancer and HIV outcomes study: Profiling the cancer centres and cohort characteristics, diagnostic pathways, and treatment approaches

• Published in: PLOS global public health Vol. 3; no. 10; p. e0002432
• Main Authors: Mapanga, Witness, Ayeni, Oluwatosin A, Chen, Wenlong Carl, Jacobson, Judith S, Neugut, Alfred I, Ruff, Paul, Cubasch, Herbert, O'Neil, Daniel S, Buccimazza, Ines, Čačala, Sharon, Stopforth, Laura W, Farrow, Hayley A, Nietz, Sarah, Phakathi, Boitumelo, Chirwa, Tobias, McCormack, Valerie A, Joffe, Maureen
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 2023; Public Library of Science (PLoS)
• Subjects: Medicine and Health Sciences
• ISSN: 2767-3375; 2767-3375
• DOI: 10.1371/journal.pgph.0002432

The South African Breast Cancer and HIV Outcomes prospective cohort (SABCHO) study was established to investigate survival determinants among HIV-positive and HIV-negative SA women with breast cancer. This paper describes common and unique characteristics of the cancer centres and their participants, examining disparities in pathways to diagnosis, treatment resources and approaches adopted to mitigate resource constraints. The Johannesburg (Jhb), Soweto (Sow), and Durban (Dbn) sites treat mainly urban, relatively better educated and more socioeconomically advantaged patients whereas the Pietermaritzburg (Pmb) and Empangeni (Emp) sites treat predominantly rural, less educated and more impoverished communities The Sow, Jhb, and Emp sites had relatively younger patients (mean ages 54 ±14.5, 55±13.7 and 54±14.3 respectively), whereas patients at the Dbn and Pmb sites, with greater representation of Asian Indian women, were relatively older (mean age 57 ±13.9 and 58 ±14.6 respectively). HIV prevalence among the cohort was high, ranging from 15%-42%, (Cohort obesity (BMI ≥ 30 kg/m2) at 60%, self-reported hypertension (41%) and diabetes (13%). Direct referral of patients from primary care clinics to cancer centre occurred only at the Sow site which uniquely ran an open clinic and where early stage (I and II) proportions were highest at 48.5%. The other sites relied on indirect patient referral from regional hospitals where significant delays in diagnostics occurred and early-stage proportions were a low (15%- 37.3%). The Emp site referred patients for all treatments to the Dbn site located 200km away; the Sow site provided surgery and endocrine treatment services but referred patients to the Jhb site 30 Km away for chemo- and radiation therapy. The Jhb, Dbn and Pmb sites all provided complete oncology treatment services. All treatment centres followed international guidelines for their treatment approaches. Findings may inform policy interventions to address national and regional disparities in breast cancer care.